GlassScriptPhysician profile
Virginia E Lawrence
NPI 1639658586
$6,631.27
in general payments reported to CMS, 2019-2025
20 companies · $770 in 2025
The $770 reported for 2025 was more than what 80% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $584 · 2022: $2,657 · 2023: $1,406 · 2024: $1,215 · 2025: $770.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,391.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,390.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,447.96 | 2021-2025 | Aurora Ev-Icd Mri Surescan, Selectsecure, Linq II |
| Boston Scientific Corporation | $819.77 | 2021-2025 | Watchman Flx, Watchman Access System, Ekosonic |
| Merck Sharp & Dohme LLC | $453.55 | 2021-2025 | Verquvo |
| Abbott Laboratories | $431.78 | 2021-2023 | Aveir |
| E.R. Squibb & Sons, L.L.C. | $389.72 | 2023-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $386.72 | 2022-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $380.06 | 2021-2024 | Farxiga, Lokelma |
| Boehringer Ingelheim Pharmaceuticals, INC. | $279.07 | 2021-2023 | Jardiance |
| Amgen INC. | $174.09 | 2022-2024 | Repatha |
| Heartflow, INC. | $145.72 | 2023 | Ffrct |
| Novo Nordisk INC | $142.20 | 2022-2025 | Wegovy |
| Abiomed | $134.93 | 2025 | |
| Pfizer INC. | $121.89 | 2021-2025 | |
| Kestra Medical Technology Services, INC. | $96.92 | 2023-2025 | Assure Wcd |
| Daiichi Sankyo INC. | $72.40 | 2023-2024 | Injectafer |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $43.59 | 2023-2024 | |
| Atricure, INC. | $41.58 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $30.21 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.65 | 2023 | Lifevest |
| Amarin Pharma, INC. | $18.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Virginia Lawrence listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.